Loading company…
Wuhan-based Wuhan HealthCare Biotechnology provides molecular diagnostic equipment and testing services for major diseases.
Based in Wuhan, China and established in 2013, Wuhan HealthCare Biotechnology Co., Ltd. provides clinical diagnosis of major diseases and molecular diagnostic products, mainly fluorescence in situ hybridization probes and equipment, for hospitals and third-party testing institutions. Its FastProbe® technology shortens detection time from three days to several hours. From 2015 to 2021 it raised venture funding from multiple investors. In August 2025 Shanghai Tellgen Life Science agreed to acquire a majority stake for CNY 291.45 million from existing shareholders.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Wuhan HealthCare Biotechnology Co., Ltd.? This is my company